353 related articles for article (PubMed ID: 31474570)
1. The Dual Roles of the Atypical Protein Kinase Cs in Cancer.
Reina-Campos M; Diaz-Meco MT; Moscat J
Cancer Cell; 2019 Sep; 36(3):218-235. PubMed ID: 31474570
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase Cλ/ι in cancer: a contextual balance of time and signals.
Moscat J; Linares JF; Duran A; Diaz-Meco MT
Trends Cell Biol; 2022 Dec; 32(12):1023-1034. PubMed ID: 35501226
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous Loss of Both Atypical Protein Kinase C Genes in the Intestinal Epithelium Drives Serrated Intestinal Cancer by Impairing Immunosurveillance.
Nakanishi Y; Duran A; L'Hermitte A; Shelton PM; Nakanishi N; Reina-Campos M; Huang J; Soldevila F; Baaten BJG; Tauriello DVF; Castilla EA; Bhangoo MS; Bao F; Sigal D; Diaz-Meco MT; Moscat J
Immunity; 2018 Dec; 49(6):1132-1147.e7. PubMed ID: 30552022
[TBL] [Abstract][Full Text] [Related]
4. A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion.
Butler AM; Scotti Buzhardt ML; Erdogan E; Li S; Inman KS; Fields AP; Murray NR
Oncotarget; 2015 Jun; 6(17):15297-310. PubMed ID: 25915428
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of atypical protein kinase C‑ι effectively reduces the malignancy of prostate cancer cells by downregulating the NF-κB signaling cascade.
Apostolatos AH; Ratnayake WS; Win-Piazza H; Apostolatos CA; Smalley T; Kang L; Salup R; Hill R; Acevedo-Duncan M
Int J Oncol; 2018 Nov; 53(5):1836-1846. PubMed ID: 30226591
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C lambda/iota (PKClambda/iota): a PKC isotype essential for the development of multicellular organisms.
Suzuki A; Akimoto K; Ohno S
J Biochem; 2003 Jan; 133(1):9-16. PubMed ID: 12761193
[TBL] [Abstract][Full Text] [Related]
7. Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis.
Ratnayake WS; Apostolatos AH; Ostrov DA; Acevedo-Duncan M
Int J Oncol; 2017 Nov; 51(5):1370-1382. PubMed ID: 29048609
[TBL] [Abstract][Full Text] [Related]
8. Editorial.
Fields AP
Adv Biol Regul; 2021 May; 80():100770. PubMed ID: 33310395
[No Abstract] [Full Text] [Related]
9. Atypical protein kinase Cι as a human oncogene and therapeutic target.
Parker PJ; Justilien V; Riou P; Linch M; Fields AP
Biochem Pharmacol; 2014 Mar; 88(1):1-11. PubMed ID: 24231509
[TBL] [Abstract][Full Text] [Related]
10. Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C.
Xiong X; Li X; Wen YA; Gao T
J Biol Chem; 2016 Nov; 291(48):25167-25178. PubMed ID: 27760826
[TBL] [Abstract][Full Text] [Related]
11. Def-6, a novel regulator of small GTPases in podocytes, acts downstream of atypical protein kinase C (aPKC) λ/ι.
Worthmann K; Leitges M; Teng B; Sestu M; Tossidou I; Samson T; Haller H; Huber TB; Schiffer M
Am J Pathol; 2013 Dec; 183(6):1945-1959. PubMed ID: 24096077
[TBL] [Abstract][Full Text] [Related]
12. The overexpression and altered localization of the atypical protein kinase C lambda/iota in breast cancer correlates with the pathologic type of these tumors.
Kojima Y; Akimoto K; Nagashima Y; Ishiguro H; Shirai S; Chishima T; Ichikawa Y; Ishikawa T; Sasaki T; Kubota Y; Inayama Y; Aoki I; Ohno S; Shimada H
Hum Pathol; 2008 Jun; 39(6):824-31. PubMed ID: 18538170
[TBL] [Abstract][Full Text] [Related]
13. Recurrent copy number gains drive PKCι expression and PKCι-dependent oncogenic signaling in human cancers.
Liu Y; Justilien V; Fields AP; Murray NR
Adv Biol Regul; 2020 Dec; 78():100754. PubMed ID: 32992230
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C: perfectly balanced.
Newton AC
Crit Rev Biochem Mol Biol; 2018 Apr; 53(2):208-230. PubMed ID: 29513138
[TBL] [Abstract][Full Text] [Related]
15. Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology.
Goel RK; Lukong KE
Cancer Metastasis Rev; 2016 Jun; 35(2):179-99. PubMed ID: 27067725
[TBL] [Abstract][Full Text] [Related]
16. The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation.
Sanz L; Sanchez P; Lallena MJ; Diaz-Meco MT; Moscat J
EMBO J; 1999 Jun; 18(11):3044-53. PubMed ID: 10356400
[TBL] [Abstract][Full Text] [Related]
17. Targeted deletion of protein kinase C lambda reveals a distribution of functions between the two atypical protein kinase C isoforms.
Soloff RS; Katayama C; Lin MY; Feramisco JR; Hedrick SM
J Immunol; 2004 Sep; 173(5):3250-60. PubMed ID: 15322187
[TBL] [Abstract][Full Text] [Related]
18. Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids.
Linch M; Sanz-Garcia M; Rosse C; Riou P; Peel N; Madsen CD; Sahai E; Downward J; Khwaja A; Dillon C; Roffey J; Cameron AJ; Parker PJ
Carcinogenesis; 2014 Feb; 35(2):396-406. PubMed ID: 24072773
[TBL] [Abstract][Full Text] [Related]
19. Relevance of atypical protein kinase C isotypes to the drug discovery process.
Jenny M; Wrulich OA; Schwaiger W; Ueberall F
Chembiochem; 2005 Mar; 6(3):491-9. PubMed ID: 15712318
[No Abstract] [Full Text] [Related]
20. Inhibition of insulin-induced glucose uptake by atypical protein kinase C isotype-specific interacting protein in 3T3-L1 adipocytes.
Kotani K; Ogawa W; Hashiramoto M; Onishi T; Ohno S; Kasuga M
J Biol Chem; 2000 Aug; 275(34):26390-5. PubMed ID: 10869347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
